SBIR/STTR Research Award

Nanomaterial Radioisotope Detectors for Intracellular Measurements

Award identifier b6dd07001537508c90f3a5611a5f48834525db095b32c6011093e78cf452d1d8Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$149,800

Program and phase

SBIR · Phase I

Award year

2022

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SCINTILLATION NANOTECHNOLOGIES INC
Proposal award date
2022-05-01
Contract end date
2023-04-30
UEI
LWZ3EXG6XRZ9
Solicitation number
PA20-047
Topic code
400

Research abstract

The capability to analyze cellular uptake of physiological and pharmacological compounds with increasing sensitivity and temporal resolution plays a critical role in understanding the underlying molecular pathways involved in human diseases and disorders. Among the most challenging analytes are those present at very low concentrations with high temporal variability, and small molecules lacking moieties amenable for optical and/or electrochemical detection. Radioisotopes (RI) facilitate highly sensitive detection of these analytes, with minimal perturbation of analyte mass and structure, compared to fluorescent labels and other molecular tags. β-particle emitters, including 32P, 33P, 35S, and 3H are commonly used as biological tracers due to the prevalence of these atoms in biological molecules. Despite the advent of new molecular analysis approaches, RI remain the gold standard in a wide range of quantitative biological, chemical and environmental studies. RI labels have played a critical role in the investigation of biological systems, for almost a century. Though new analytical approaches, including mass spectrometry, now allow sensitive detection of label-free mixtures, the high mass sensitivity of radioassays is unparalleled, making radioassays indispensable for a range of biochemical and biomedical studies. Furthermore, improved detection capabilities that enable a broader application of RI detection to new biomedical research questions should prove transformational in high sensitivity biomolecular analyses. In this SBIR application, we propose to continue development of proprietary, IP-protected, innovative core-shell nanomaterials capable of real-time, and in some cases, molecularly selective, detection of low energy RIs directly in aqueous samples. These nanomaterials be demonstrated for intracellular measurement of low energy RI- labeled analytes. Such measurements would seed new research investigations and would position Scintillation Nanotechnologies INC as the only commercial entity providing products that perform such measurements.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

4 SBIR/STTR records share this UEI (2020–2024). Reported award amounts total $826,147. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.